PVC Clinical Trials & Post-Marketing Surveillance 3

Question 1

A sponsor identifies a new, potentially serious risk for a drug under clinical development. Within how many calendar days must a SUSAR be reported to the FDA?

Accepted Answer

7 days for fatal/life-threatening; 15 days for other serious unexpected

Answer

FDA regulations (21 CFR 312.32) require 7-day reporting for fatal or life-threatening SUSARs and 15-day reporting for other serious unexpected reactions.

Question 2

What distinguishes an 'unexpected' adverse drug reaction from an 'expected' one in the context of clinical trial safety reporting?

Accepted Answer

The nature or severity is not consistent with the Investigator's Brochure

Answer

An unexpected ADR is one whose nature, severity, or specificity is not consistent with the reference safety information in the Investigator's Brochure.

Question 3

In the context of post-marketing surveillance, what is a 'risk minimization measure' (RMM)?

Accepted Answer

An intervention to prevent or reduce the probability or severity of an adverse outcome

Answer

Risk minimization measures are interventions beyond standard labeling designed to prevent or reduce adverse reactions associated with a medicinal product.

Question 4

Which phase of clinical development is primarily designed to assess dose-response relationships and short-term safety in a larger patient population?

Accepted Answer

Phase II

Answer

Phase II trials evaluate efficacy, optimal dose ranges, and safety in the target patient population, typically enrolling hundreds of subjects.

Question 5

A pharmacovigilance team identifies a signal suggesting a cardiac risk with a newly marketed antibiotic. What is the typical sequence of signal management steps?

Accepted Answer

Detection → Validation → Prioritization → Assessment → Recommendation

Answer

The ICH E2E signal management framework follows the sequence: detection, validation, prioritization, assessment, and recommendation for action.

(PVC) Pharmacovigilance Certification Practice Test

(PVC) Pharmacovigilance Certification Practice Test

PVC Clinical Trials & Post-Marketing Surveillance 3